Structure Therapeutics (GPCR) Current Leases (2022 - 2026)

Structure Therapeutics' Current Leases history runs 5 years deep, the most recent figure standing at $2.6 million for Q1 2026.

• In Q1 2026, Current Leases rose 5.58% year-over-year to $2.6 million; the TTM figure through Mar 2026 stood at $2.6 million (up 5.58% YoY), while the FY2025 annual figure was $2.9 million, up 69.49% from the prior year.
• Current Leases for Q1 2026 stood at $2.6 million, down from $2.9 million in the prior quarter.
• The five-year high for Current Leases was $2.9 million in Q4 2025, with the low at $73000.0 in Q2 2023.
• The 5-year median for Current Leases is $1.7 million (2024), against an average of $1.6 million.
• The sharpest annual moves came in 2024 and 2026: Current Leases jumped 2131.51% in 2024, then increased 5.58% in 2026.
• Structure Therapeutics' Current Leases stood at $260000.0 in 2022, then soared by 453.85% to $1.4 million in 2023, then grew by 17.92% to $1.7 million in 2024, then soared by 69.49% to $2.9 million in 2025, then dropped by 9.35% to $2.6 million in 2026.
• Business Quant data shows GPCR's Current Leases at $2.6 million in Q1 2026, $2.9 million in Q4 2025, and $2.8 million in Q3 2025.